ArticleTransfusion2026
The different barriers to donating plasma in plasma donors, whole blood donors, and non-donors in the United Kingdom.
Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPlasma donation is critical for the production of plasma-derived medicinal products, yet donor recruitment and retention remains challenging within a volunteer system. This paper explores deterrents to plasma donation among current plasma donors, whole-blood donors, lapsed whole-blood donors, and non-donors in the United Kingdom, and self-reported post-donation symptoms in plasma donors. STUDY DESIGN AND
methodsAn online survey of the UK general public (current and lapsed blood donors, and non-donors: n = 2861) and English current plasma donors (n = 448), and one-to-one interviews (n = 25) with plasma donors were conducted. Participants identified deterrents to plasma donation, and plasma donors described post-donation symptoms.
resultsPlasma donors reported distinct deterrents around time constraints and ineligibility. There were differences by donor status. Blood, plasma, and non-donors all report pain, lack of travel compensation, involvement of private companies and incentives as concerns. Lack of awareness was salient for non-donors and blood donors, while non-donors had concerns about neurodiversity and donors about incentives to change. Being deferred on the day, described as an embarrassing "walk of shame," was a unique deterrent to plasma donors. 11.8% (53/488) of plasma donors reported symptoms of feeling ill after donation. Of these, 73% (n = 38) occurred and were managed in center (e.g., feeling faint, bruising) and 25% (n = 13) outside of the center (e.g., feeling faint) and managed by the donor (2% other). DISCUSSION: Different profiles of deterrents were observed for plasma donors compared to whole blood and non-donors. Recommendations for the recruitment and retention of plasma donors in England are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.